Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082590435> ?p ?o ?g. }
- W3082590435 abstract "ABSTRACT Objectives The clinical performance of the BD Veritor™ System for Rapid Detection of SARS-CoV-2 antigen (Veritor), a chromatographic immunoassay that detects the SARS-CoV-2 nucleocapsid antigen as a point-of-care test, was evaluated on nasal specimens from individuals with COVID-19 symptoms. Methods and Materials Two studies were completed to determine clinical performance. In the first study, nasal specimens and either nasopharyngeal or oropharyngeal specimens from 251 participants with COVID-19 symptoms (≤7 days from symptom onset [DSO]), ≥18 years of age, were utilized to compare Veritor with the Lyra ® SARS-CoV-2 PCR Assay (Lyra). In the second study, nasal specimens from 361 participants with COVID-19 symptoms (≤5 DSO), ≥18 years of age, were utilized to compare performance of Veritor to that of the Sofia ® 2 SARS Antigen FIA test (Sofia 2). Positive, negative, and overall percent agreement (PPA, NPA, and OPA, respectively) were the primary outcomes. Results In study 1, PPA for Veritor, compared to Lyra, ranged from 81.8%-87.5% for 0-1 through 0-6 DSO ranges. In study 2, Veritor had a PPA, NPA, and OPA of 97.4%, 98.1%, and 98.1%, respectively, with Sofia 2. Discordant analysis showed one Lyra positive missed by Veritor and five Lyra positives missed by Sofia 2; one Veritor positive result was negative by Lyra. Conclusions Veritor met FDA-EUA acceptance criteria for SARS-CoV-2 antigen testing (≥80% PPA point estimate) for the 0-5 and 0-6 DSO ranges. Veritor and Sofia 2 showed a high degree of agreement for SARS-CoV-2 detection. The Veritor test should facilitate rapid and reliable results for COVID-19 diagnosis utilizing easy-to-collect nasal swabs. Summary The BD Veritor SARS-CoV-2 antigen test met FDA-EUA acceptance criteria for SARS-CoV-2 antigen testing for subjects with COVID-19 symptoms (0-5 days post-onset). BD Veritor and Quidel Sofia 2 antigen tests had good agreement for SARS-CoV-2 detection; discordant analysis favored Veritor." @default.
- W3082590435 created "2020-09-08" @default.
- W3082590435 creator A5002032384 @default.
- W3082590435 creator A5005420006 @default.
- W3082590435 creator A5009092266 @default.
- W3082590435 creator A5014860145 @default.
- W3082590435 creator A5022942765 @default.
- W3082590435 creator A5040063510 @default.
- W3082590435 creator A5042027578 @default.
- W3082590435 creator A5045383513 @default.
- W3082590435 creator A5051967074 @default.
- W3082590435 creator A5052744046 @default.
- W3082590435 creator A5071656438 @default.
- W3082590435 creator A5073347116 @default.
- W3082590435 creator A5076237489 @default.
- W3082590435 creator A5090005867 @default.
- W3082590435 date "2020-09-03" @default.
- W3082590435 modified "2023-09-23" @default.
- W3082590435 title "Clinical evaluation of BD Veritor<sup>™</sup>SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia<sup>®</sup>2 SARS Antigen point-of-care test" @default.
- W3082590435 cites W1830758076 @default.
- W3082590435 cites W2069890151 @default.
- W3082590435 cites W2116586125 @default.
- W3082590435 cites W2134429257 @default.
- W3082590435 cites W3005827208 @default.
- W3082590435 cites W3006255311 @default.
- W3082590435 cites W3007878828 @default.
- W3082590435 cites W3008028633 @default.
- W3082590435 cites W3011398105 @default.
- W3082590435 cites W3011894826 @default.
- W3082590435 cites W3012568633 @default.
- W3082590435 cites W3013893137 @default.
- W3082590435 cites W3016610966 @default.
- W3082590435 cites W3017119695 @default.
- W3082590435 cites W3018166943 @default.
- W3082590435 cites W3019462775 @default.
- W3082590435 cites W3026002191 @default.
- W3082590435 cites W3034533137 @default.
- W3082590435 cites W3034651359 @default.
- W3082590435 cites W3037781831 @default.
- W3082590435 cites W3041752529 @default.
- W3082590435 doi "https://doi.org/10.1101/2020.09.01.20185777" @default.
- W3082590435 hasPublicationYear "2020" @default.
- W3082590435 type Work @default.
- W3082590435 sameAs 3082590435 @default.
- W3082590435 citedByCount "6" @default.
- W3082590435 countsByYear W30825904352020 @default.
- W3082590435 countsByYear W30825904352021 @default.
- W3082590435 crossrefType "posted-content" @default.
- W3082590435 hasAuthorship W3082590435A5002032384 @default.
- W3082590435 hasAuthorship W3082590435A5005420006 @default.
- W3082590435 hasAuthorship W3082590435A5009092266 @default.
- W3082590435 hasAuthorship W3082590435A5014860145 @default.
- W3082590435 hasAuthorship W3082590435A5022942765 @default.
- W3082590435 hasAuthorship W3082590435A5040063510 @default.
- W3082590435 hasAuthorship W3082590435A5042027578 @default.
- W3082590435 hasAuthorship W3082590435A5045383513 @default.
- W3082590435 hasAuthorship W3082590435A5051967074 @default.
- W3082590435 hasAuthorship W3082590435A5052744046 @default.
- W3082590435 hasAuthorship W3082590435A5071656438 @default.
- W3082590435 hasAuthorship W3082590435A5073347116 @default.
- W3082590435 hasAuthorship W3082590435A5076237489 @default.
- W3082590435 hasAuthorship W3082590435A5090005867 @default.
- W3082590435 hasBestOaLocation W30825904351 @default.
- W3082590435 hasConcept C126322002 @default.
- W3082590435 hasConcept C142724271 @default.
- W3082590435 hasConcept C147483822 @default.
- W3082590435 hasConcept C203014093 @default.
- W3082590435 hasConcept C2779134260 @default.
- W3082590435 hasConcept C3007834351 @default.
- W3082590435 hasConcept C3008058167 @default.
- W3082590435 hasConcept C42972112 @default.
- W3082590435 hasConcept C51915194 @default.
- W3082590435 hasConcept C524204448 @default.
- W3082590435 hasConcept C64841741 @default.
- W3082590435 hasConcept C71924100 @default.
- W3082590435 hasConceptScore W3082590435C126322002 @default.
- W3082590435 hasConceptScore W3082590435C142724271 @default.
- W3082590435 hasConceptScore W3082590435C147483822 @default.
- W3082590435 hasConceptScore W3082590435C203014093 @default.
- W3082590435 hasConceptScore W3082590435C2779134260 @default.
- W3082590435 hasConceptScore W3082590435C3007834351 @default.
- W3082590435 hasConceptScore W3082590435C3008058167 @default.
- W3082590435 hasConceptScore W3082590435C42972112 @default.
- W3082590435 hasConceptScore W3082590435C51915194 @default.
- W3082590435 hasConceptScore W3082590435C524204448 @default.
- W3082590435 hasConceptScore W3082590435C64841741 @default.
- W3082590435 hasConceptScore W3082590435C71924100 @default.
- W3082590435 hasLocation W30825904351 @default.
- W3082590435 hasLocation W30825904352 @default.
- W3082590435 hasOpenAccess W3082590435 @default.
- W3082590435 hasPrimaryLocation W30825904351 @default.
- W3082590435 hasRelatedWork W3048104891 @default.
- W3082590435 hasRelatedWork W3091985319 @default.
- W3082590435 hasRelatedWork W3092089555 @default.
- W3082590435 hasRelatedWork W3108643339 @default.
- W3082590435 hasRelatedWork W3117023831 @default.
- W3082590435 hasRelatedWork W3178467701 @default.
- W3082590435 hasRelatedWork W3186323748 @default.
- W3082590435 hasRelatedWork W3192499765 @default.
- W3082590435 hasRelatedWork W4245826654 @default.